Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RDF | Ann: H1 FY19 Performance Summary | 19/03/19 | 6 | 1.9K | |||
|
|||||||
RDF | Ann: Redflex Investor Conference Call (Friday March 1, 2019) | 27/02/19 | 0 | 112 | |||
|
|||||||
RDF | Ann: FY2019 First Half Year Results | 25/02/19 | 0 | 105 | |||
|
|||||||
RDF | Ann: FY2019 First Half Year Earnings Update | 21/02/19 | 4 | 844 | |||
|
|||||||
RDF | Ann: Amendment to Western Alliance Bank Credit Facility | 07/02/19 | 0 | 121 | |||
|
|||||||
RDF | Ann: Q2 FY19 Sales Activity Update | 30/01/19 | 10 | 1.5K | |||
|
|||||||
RDF | News: RDF Redflex Holdings Sees H1 FY2019 EBITDA Between A$8.7 Mln & A$9.2 Mln | 30/01/19 | 0 | 98 | |||
|
|||||||
RDF | Ann: Performance Rights | 30/01/19 | 0 | 144 | |||
|
See All Discussions